November 18, 2015
11 am to 12 pm EST

Sponsored by
Wasatch Microfluidics logo

Webinar Description:

This webinar will demonstrate the power of high-throughput SPR imaging to uncover unique epitope behaviors using antibodies targeting a viral protein as an example. In a handful of epitope mapping, binning, and receptor competition experiments, these studies accurately identified trends and behaviors that previously required multiple decades and technologies to accomplish. A real time analysis of epitope binning data will also be performed to emphasize the novel data reduction capabilities available to rapidly inform decisions.

Learning Objectives:

  • The critical role antibody epitope plays in functional and clinical outcomes
  • What makes Wasatch Microfluidics’ SPRi platform truly unique for epitope characterization
  • The power of screening large panels of mAbs to elucidate meaningful differences in epitope engagement
  • How data analysis tools for epitope characterization can drive therapeutic discovery

Speakers:

Adam MilesAdam Miles

Senior Applications Scientist

Wasatch Microfluidics, Inc.

 

Adam is a Senior Applications Scientist at Wasatch Microfluidics, Inc. He helped develop the company’s CFM from the earliest stages of the technology through to the current instrument, and has spearheaded the application development for the CFM arraying capabilities with the IBIS MX96 SPRi Array. In addition to continuing his applications, software and hardware development work for the CFM/MX96 SPRi Array platform, Adam also supports customers on the West Coast and manages Wasatch Microfluidics’ Interaction Lab.

Tina CairnsTina Cairns, Ph.D.

Staff Scientist

Cohen-Eisenberg Lab, University of Pennsylvania

 

Tina is a Staff Scientist for the Cohen-Eisenberg Laboratory at the University of Pennsylvania. Her background is in virology, specifically retroviruses (virus egress) and herpesviruses (virus entry). Recently, she has authored several research papers on dissecting the antibody response in humans to herpes simplex virus, by either vaccination or natural infection.

Moderator:

Noah DittoNoah Ditto

Senior Applications Scientist

Wasatch Microfluidics, Inc.

 

Noah is a Senior Applications Scientist for Eastern North America at Wasatch Microfluidics supporting customer driven applications and platform development. His background is in analytical technologies focused on characterizing recombinant and native proteins and peptides for biopharmaceutical drug discovery and early development. Previously Noah worked for nearly 9 years as a research scientist at Bristol-Myers Squibb.



Cost: No cost!

Schedule conflict? Register and you'll receive a copy of the recording!